15
2009
Renal denervation: current implications and future perspectives

Jianzhong Xu , Dagmara Hering , Yusuke Sata , Antony Walton
Clinical Science 126 ( 1) 41 -53

19
2014
Elevated cardiac risk in patients with major depressive disorder.

RICHARD G. BAYLES , TYE DAWOOD , ELISABETH A. LAMBERT , MARKUS P. SCHLAICH
American Journal of Psychiatry 165 ( 1) 137 -137

2
2008
The Schlager mouse as a model of altered retinal phenotype.

VanceB Matthews , LakshiniY Herat , AaronL Magno , MárcioG Kiuchi
Neural Regeneration Research 15 ( 3) 512 -518

4
2020
Sympathetic stimulation with norepinephrine may come at a cost.

VanceB Matthews , LakshiniY Herat , MarkusP Schlaich
Neural Regeneration Research 14 ( 6) 977 -978

2019
Angiotensin II and norepinephrine release: interaction and effects on the heart. Commentary

Guido GRASSI , Markus P SCHLAICH , David M KAYE , Elisabeth LAMBERT
Journal of hypertension 23 ( 5) 941 -943

2005
LONG-TERM OUTCOMES FOLLOWING RADIOFREQUENCY RENAL DENERVATION: META-ANALYSIS OF 18 REPORTS INCLUDING PATIENT LEVEL DATA FROM THE GLOBAL SYMPLICITY REGISTRY DEFINE

Felix Mahfoud , Giuseppe Mancia , Roland E Schmieder , Luis Ruilope
Journal of the American College of Cardiology 83 ( 13_Supplement) 1032 -1032

2024
SGLT1/2 inhibition improves glycemic control and multi-organ protection in type 1 diabetes

Lakshini Yasaswi Herat , Jennifer Rose Matthews , Moira Hibbs , Elizabeth Piroska Rakoczy
Iscience 26 ( 8)

2
2023
Evaluation of barriers to the timely detection of Primary Aldosteronism: a survey of the general community in Australia

Jordan H Lai , StellaMay Gwini , Gang Chen , Katrina M Long
Annual Scientific Meeting Report of the High Blood Pressure Research Council of Australia 2021

2021
Chronic distress and acute vascular stress responses associated with ambulatory blood pressure in low-testosterone African men: the SABPA Study

Nicholaas Theodore Malan , Tobias Stalder , Markus Peter Schlaich , Gavin William Lambert
Journal of Human Hypertension 28 ( 6) 393 -398

3
2014
Cardiometabolic challenges 3

LOUISE BURRELL , GEMMA FIGTREE , NICK SR LAN , JING PANG
Focus

2023
Putting the evidence into clinical practice–the 2021 ESH Position Statement on Renal Denervation

MARKUS P SCHLAICH
2 LEWIS LANDSBERG HAS LEFT US 3 UPDATE FROM THE EXECUTIVE 47 -47

2021
Resistant hypertension

SAYEH HEIDARI NEJAD , MARKUS P SCHLAICH

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first-line antihypertensive therapy

R Carnagarin , MARKUS Schlaich
European Heart Journal 43 ( Supplement_1) ehab849. 151 -ehab849. 151

1
2022
Rosuvastatin does not affect intraglomerular haemodynamics in patients with hypercholesterolemia

C Ott , MR Schlaich , BMW Schmidt , SI Titze
JOURNAL OF HYPERTENSION 25 S17 -S17

1
2007
Renal denervation and pulmonary vein isolation in patients with drug resistant hypertension and symptomatic atrial fibrillation

Dagmara Hering , Markus P Schlaich , Peter Kistler , Alex J McLellan
Journal of Atrial Fibrillation 7 ( 4) 1165

1
2014
Abstract P608: Role Of Nitric Oxide In The Pathophysiology Of Hypertension Associated With Low Nephron Endowment.

Reetu R Singh , Lawerance K Easton , Markus P Schlaich , Geoff A Head
Hypertension 66

2015